Back to Journals » Neuropsychiatric Disease and Treatment » Volume 18

Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study

Total article views   HTML views PDF downloads Totals
3,687 Dovepress* 3,507+ 69 3,576
PubMed Central* 180 53 233
Totals 3,687 122 3,809
*Since 3 May 2022

View citations on PubMed Central and Google Scholar